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Distinct mechanisms regulate Cdx2 
expression in the blastocyst and in 
trophoblast stem cells
Teresa Rayon1,†,*, Sergio Menchero1,*, Isabel Rollán1, Inmaculada Ors1,‡, Anne Helness2,§, 
Miguel Crespo1,#, Andres Nieto3, Véronique Azuara2, Janet Rossant3,4 & Miguel Manzanares1
The first intercellular differences during mammalian embryogenesis arise in the blastocyst, producing 
the inner cell mass and the trophectoderm. The trophectoderm is the first extraembryonic tissue and 
does not contribute to the embryo proper, its differentiation instead forming tissues that sustain 
embryonic development. Crucial roles in extraembryonic differentiation have been identified for 
certain transcription factors, but a comprehensive picture of the regulation of this early specification 
is still lacking. Here, we investigated whether the regulatory mechanisms involved in Cdx2 expression 
in the blastocyst are also utilized in the postimplantation embryo. We analyzed an enhancer that is 
regulated through Hippo and Notch in the blastocyst trophectoderm, unexpectedly finding that it 
is inactive in the extraembryonic structures at postimplantation stages. Further analysis identified 
other Cdx2 regulatory elements including a stem-cell specific regulatory sequence and an element 
that drives reporter expression in the trophectoderm, a subset of cells in the extraembryonic region 
of the postimplantation embryo and in trophoblast stem cells. The cross-comparison in this study of 
cis-regulatory elements employed in the blastocyst, stem cell populations and the postimplantation 
embryo provides new insights into early mammalian development and suggests a two-step mechanism 
in Cdx2 regulation.
By the time of blastocyst implantation in the uterus, the three first lineages of the embryo have been established, 
are committed in terms of their differentiation potential and they are no longer interconvertible. The blastocyst is 
initially composed of an outer epithelial monolayer of trophectoderm (TE) that covers the inner cell mass (ICM) 
and the fluid-filled blastocoel cavity. Soon after, the ICM separates into the epiblast and the primitive endoderm. 
After implantation, the epiblast remains pluripotent and will give rise to all tissues of the embryo. On the other 
hand, the primitive endoderm and the TE will generate all extraembryonic structures needed for embryo support 
and nourishment through development. The primitive endoderm forms the parietal and visceral endoderm layers 
of the yolk sac, whereas the TE generates the trophoblast-derived structures of the embryo: parietal trophoblast 
giant cells that line the implantation site, the extraembryonic and chorionic ectoderm, the ectoplacental cone, and 
later the various trophoblast cell types of the mature placenta1.
This lineage restriction is mirrored in three different stem cell populations that can be derived from the blasto-
cyst: Embryonic Stem (ES), Trophoblast Stem (TS), and eXtraembryonic ENdoderm stem (XEN) cells. All three 
cell types recapitulate the lineage of their appropriate blastocyst precursor when injected into blastocysts to gener-
ate chimeras2. In addition, TS cells can be derived not only from the blastocyst but also from the Extraembryonic 
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Ectoderm (ExE) up to embryonic stage (E) 8.5 of the postimplantation mouse embryo3, raising the question of 
whether TS cells reach a common state during the process of derivation, no longer resembling the tissue or stage 
from which they were initially derived. ES, TS and XEN cells share some features of the regulatory networks active 
in their lineage of origin, and serve as an in vitro tool for investigating how these populations are established and 
how the set of core transcription factors responsible for their identity is assembled. Transcription factors (TFs) are 
essential in cell-type specification, and their expression is determined by how they are regulated. TFs can play a 
deterministic role, as shown in experiments in which forced TF expression reprograms cell-type specification4–7. 
Cdx2 is the core TF responsible for trophectoderm development. Cdx2 mutants die in the blastocyst stage as the 
TE is not properly specified and it fails to maintain epithelial integrity8. Also, Cdx2 is crucial in TS cells derivation 
as shown by the fact that TS cells cannot be derived from Cdx2-mutant blastocysts, overexpression of Cdx2 in 
ES cells forces their conversion to TS cells9, and Cdx2 is indispensable for TS-cell self-renewal8. We previously 
characterized a TE-specific enhancer (TEE) for Cdx2 that faithfully recapitulates the early onset of Cdx2 expres-
sion during preimplantation development10. To better understand the regulation of Cdx2 during extraembryonic 
development, we analyzed TEE activity in the ExE and TS cells, unexpectedly finding that this regulatory element 
is not active in these instances. Further analysis of the Cdx2 genomic region identified novel regulatory elements 
that drive reporter activity in TS cells and in a subset of extraembryonic tissues of the postimplantation embryo. 
These results reveal an early regulatory switch in Cdx2 expression and show that different inputs are needed to 
drive Cdx2 expression in the blastocyst trophectoderm and in trophoblast stem cells.
Results
The TE-specific enhancer for Cdx2 is inactive in extraembryonic tissues of the postimplantation 
embryo. We previously characterized an enhancer element (TEE) from Cdx2 that drives reporter expression 
specifically in the blastocyst TE10. Given that Cdx2 expression persists in the ExE of the postimplantation embryo, 
we examined TEE activity after the blastocyst stage in lacZ- and mRFP- reporter lines10. We expected to detect 
TEE mediated expression in TE derivatives that normally express Cdx2, such as the ExE of the early embryo at 
E6.5 and E7.5 (Fig. 1a,b). Surprisingly, we did not detect any reporter activity in the TEE reporter mouse lines 
(Fig. 1c,d), despite embryos at blastocyst stage from these same lines showed consistent and reproducible reporter 
expression as we have previously shown10. We confirmed this observation by qPCR analysis of single embryos 
at E3.5 and E7.5 of Cdx2, together with lacZ or mRFP for the TEE-lacZ and TEE-mRFP lines, respectively. We 
observed high expression of the reporters in transgenic blastocysts but not in the extraembryonic portion at E7.5. 
On the contrary, the expression of Cdx2 in the same samples was comparable for wild type and both TEE-lacZ 
and TEE-mRFP embryos (Supplementary Fig. S1a).
To determine whether the TEE is switched off at the time of implantation, we cultured E3.5 blastocysts for an 
extra 48 h or 72 h hours in TS derivation conditions, as an in vitro model mirroring implantation in the uterus11. 
Under these conditions, blastocysts hatch from the zona pellucida and adhere to the dish, forming outgrowths. 
After 48 h in culture, embryos cultured starting from E3.5 contained 75.7% CDX2-positive cells, but after culture 
for a further 24 h this figure had dropped to 22.8% (Supplementary Fig. S1b,c). This is most likely due to loss of 
Cdx2 expression during the differentiation of extraembryonic tissues8. We then cultured heterozygous blastocysts 
from the TEE-lacZ mouse line (Fig. 1e) for two days to examine reporter expression driven by the TEE upon 
implantation (Fig. 1f). β -galactosidase expression was detected in a few cells of just 3 out of 19 TEE-lacZ geno-
typed outgrowths after 48 h culture. Thus, in 84.21% of cases, reporter expression driven by the TEE was silenced 
within 2 days of outgrowth culture, despite continued robust Cdx2 expression by the large majority of cells in the 
explant. These results indicate that the TEE is inactivated upon implantation, and suggests differential enhancer 
usage for Cdx2 in the pre- and postimplantation embryo.
The TE-specific Cdx2 enhancer is inactive in trophoblast stem cells but is reactivated in blasto-
cyst chimeras. To examine the dynamics of Cdx2 expression in trophectoderm-derived lineages, we derived 
TS cells from blastocysts of mRFP- and lacZ- TEE reporter mouse lines (TSR and TSL, respectively). Of 19 inde-
pendent cell clones (12 TSL and 7 TSR), 4 TSL and 2 TSR clones expressed comparable levels of trophectoderm 
pluripotency markers (Cdx2, Eomes, Esrrb and Fgfr2; Supplementary Fig. S2c) and trophoblast differentiation 
markers (Stra13 and Hand1; Supplementary Fig. S2d) to wild type TS cells, and retained their capacity to differen-
tiate to trophoblast giant cells upon FGF4 withdrawal (Supplementary Fig. S2a,b,e–g)3,9,12. The TSL cells, derived 
from the TEE-lacZ mouse line, did not express TEE-driven β -galactosidase (data not shown); similarly, the TSR 
cells did not express mRFP (Fig. 2a). Hence, TS cells do not activate the TEE, as also occurs in the ExE, and con-
trary to the robust TEE activity observed in the blastocyst10. These results suggest that TS cells are more related to 
ExE than to TE cells from the blastocyst regarding the regulation of Cdx2.
The definitive demonstration that TS cells retain multipotent stem cell features, other than their trophoblast 
gene expression profile and differentiation potential, is the ability to contribute to the TE lineages when injected 
back into the preimplantation embryo. We therefore tested if TSR cells could indeed contribute to the TE and, 
if so, if they re-expressed mRFP directed by the TEE when located in the embryo. TSR cells were injected into 
morula stage embryos and their contribution to the TE of the blastocyst was assessed 24 h later. Injected cells mix 
with host cells, resulting in the development of a mosaic embryo. Of 18 injected embryos, 8 (44.4%) contained 
mRFP positive cells at the blastocyst stage (Fig. 2b). All cells expressing mRFP were also positive for CDX2 pro-
tein expression, and an average of 2 CDX2-positive cells per blastocyst were mRFP+ and thus derived from the 
injected TSR cells (Fig. 2b). In some cases we found mRFP positive cells in the subzonal space that had not inte-
grated in the blastocyst. These cells were most likely dying, as they were not stained for DAPI.
To track TSR cells in injected blastocysts, we first infected them with a lentiviral GFP construct (Fig. 2c) and 
sorted them immediately before injection into morulae (Fig. 2d). Of 13 injected embryos, 6 blastocysts showed 
GFP+ cells (46.2%). An average of 3 lentiviral-transduced TSR cells were counted per blastocyst. From those, 1 or 
www.nature.com/scientificreports/
3Scientific RepoRts | 6:27139 | DOI: 10.1038/srep27139
2 injected cells re-expressed the nuclear red fluorescent reporter (Fig. 2e). The mRFP-negative TSR-derived cells 
were located outside the TE, most likely dying, and this might be why they did not properly activate the enhancer. 
These experiments thus show that TSR cells can contribute to the TE, and can reactivate TEE-driven reporter 
expression when located in the appropriate cellular context.
Chromatin landscape and regulatory activities of the Cdx2 locus in TS cells. To identify other 
putative regulatory elements that could drive Cdx2 expression in TS cells and the ExE, we performed chromatin 
immunoprecipitation, targeting histone modifications associated with promoter and enhancer activity, and then 
conducted qPCR with primers spanning the Cdx2 locus; the primers covered the TEE (amplicons 8–12), an 
upstream intergenic region (amplicons 6–7), the Cdx2 promoter (promoter), the first intron (amplicons 3–5), and 
a downstream region (amplicon 2) shown to have enhancer activity in intestinal cells (Fig. 3a)13. We included the 
promoter of the housekeeping gene Actin as a positive control, and the Nanog promoter, which is not expressed 
in TS cells, as a negative control. ChIP-qPCR for H3K4me3 and H3K4me1 showed that, as expected, the Cdx2 
promoter region was enriched for H3K4me3 and depleted for H3K4me1. Consistent with the TEE being inactive 
in TS cells, both marks were completely absent from this region (amplicons 8–12), as well as from the upstream 
and downstream regions (Fig. 3b). In contrast, a region from the first intron of Cdx2 showed enrichment for 
H3K4me1 and H3K4me3 (amplicon 4; Fig. 3b).
Figure 1. The Cdx2 TEE is inactive in the postimplantation embryo and is progressively inactivated in 
blastocyst outgrowths. (a) Diagram of Cdx2 expression at blastocyst and postimplantation stages (red).  
(b) Expression of Cdx2 at E6.5 is limited to the extraembryonic ectoderm (ExE). (c) β -galactosidase 
staining in the TEE–lacZ reporter line at E6.5, showing lack of reporter activity. (d) CDX2 expression 
(green) and TEE activity (red) in a E7.5 embryo of the TEE-mRFP line. CDX2 and mRFP were detected by 
immunohistochemistry with anti-CDX2 and anti-DsRed antibodies. Nuclei are counterstained with DAPI. 
CDX2 is present in extraembryonic tissue, while TEE activity is absent. (e) β -galactosidase staining in the TEE 
-lacZ reporter line at blastocyst stage and (f) in two outgrowths of the same line (#6 and #19). Scale bar, 110 μ m 
(b–d), 10 μ m (e), and 50 μ m (f).
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We conducted reporter assays in TS cells to test the transcriptional regulatory activity of selected fragments 
(Fig. 3a,c). These fragments were the 1.3 kb TEE10; fragment #1, a 500 bp element in the first intron of Cdx2 that 
includes amplicon 4 (Fig. 3b) and has been shown to have enhancer activity in the blastocyst14; and fragment 
#2, a 1.8 kbp sequence downstream of Cdx2 that includes amplicon 2 (Fig. 3b) and has been characterized as an 
enhancer driving expression in the gut caudal to the stomach13. Genomic fragments were cloned in the same 
mRFP reporter construct that was used for mouse transgenics10. Transfection of wild-type TS cells with the TEE 
showed no significant activity above that of empty vector, consistent with its lack of activity in TSR and TSL cells 
(Fig. 2a) and the absence of histone marks for enhancer activity (Fig. 3b). Transfection with fragment #2 yielded 
no detectable reporter expression, suggesting that it is a gut-specific enhancer and not active in extraembryonic 
Figure 2. The TE-specific Cdx2 enhancer is inactive in trophoblast stem cells but is reactivated in blastocyst 
chimeras. (a) TSR cells do not show TEE-driven mRFP expression. Cells were stained for mRFP (red), CDX2 
(green) and DAPI (blue). Scale bar 20 μ m (b) TSR cells re-express the TEE-driven mRFP reporter when injected 
into embryos. Embryos were stained for mRFP (red), CDX2 (green) and DAPI (blue). Scale bar 20 μ m (b) GFP-
infected TSR cells. The left panel shows a brightfield image. The right panel shows GFP-expressing TS cells.  
(d) Injection of GFP+ TSR cells into a morula. (e) GFP-infected TSR cells re-express the TEE-driven mRFP 
reporter in the blastocyst. Flourescent signals from expression of GFP (green) and mRFP (red). White 
arrowheads point to GFP+ /mRFP+ TSR cells, grey arrowheads show GFP+ /mRFP− TSR cells. Scale bar, 10 μ m.
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cell types. In contrast, fragment #1 drove reporter expression in TS cells (Fig. 3c), in line with the active histone 
marks we identified.
To test if these regulatory regions direct reporter expression during TE lineage specification, we used the 
ZHBTc4 ES cell line, which transdifferentiates to a TS phenotype upon downregulation of Oct4. This process has 
been suggested to mimic the first lineage choice and the early distinction between TE and ICM. Upon addition 
of tetracycline (Tc), ZHBTc4 ES cells repress Oct4, switch off the gene regulatory pluripotency program, con-
vert to TS cells, and upregulate Cdx29. Immunohistochemical analysis confirmed downregulation of OCT4 and 
upregulation of CDX2 at 48 h after Tc administration in cells cultured in EMFI-TS medium (TS cell medium) 
(Supplementary Fig. S3a,b). Expression profiling of Oct4, Nanog and Cdx2 by qPCR 48 h after Tc administra-
tion in ES culture medium detected strong reductions in Oct4 and Nanog, concomitant with upregulation of 
Cdx2 (Supplementary Fig. S3c). Cdx2 upregulation was even stronger when cells were cultured in EMFI-TS 
medium, probably because this medium favors TS cell self-renewal and maintenance (Supplementary Fig. S3c). 
Next, we transfected ZHBTc4 ES cells with either empty vector, the distal enhancer of Oct4 as positive control 
(Oct4DE)15, or the Cdx2 locus fragments used in the TS cell transfection assays. Oct4DE directed robust expres-
sion of RFP after 48 h culture in ES medium, and fragment #1 showed comparably moderate expression (Fig. 3d). 
Culture in EMFI-TS medium and addition of Tc markedly reduced Oct4DE and fragment #1 activities. This 
could seem surprising, as fragment #1 is active in TS cells. However, this region contains an Oct4 binding site16 
that could account for its expression in ES cells as well as for its reduced expression upon OCT4 downregulation. 
Furthermore, it has been described that conversion of ZHBTc4 ES cells to TS-like cells is a gradual process17, so it 
is possible that this fragment is not fully active until complete transdifferentiation to TS cells has occurred. In con-
trast, no RFP activity could be detected in cells transfected with the TEE or fragment #2 (Fig. 3d). These results 
show that the TEE is not activated during conversion of ES to TS cells upon Oct4 downregulation.
Figure 3. Activity of regulatory elements in the Cdx2 locus. (a) Diagram of the Cdx2 locus, showing relative 
positions of primers selected for ChIP-qPCR (2–12) and of the selected regulatory elements. (b) Relative 
enrichment over IgG of H3K4me1 (orange) and H3K4me3 (blue) along the Cdx2 locus in the chromatin of 
TS cells; Actin promoter, positive control; Nanog promoter, negative control. Data are means ± s.e.m. n = 2. 
(c) TS transfection of different Cdx2 regulatory fragments. Fragments were tested for regulatory capacity, and 
expression was compared to level obtained with empty vector (mock). Data are means ± s.e.m. n = 3.  
*** p < 0.001 compared with mock (Student’s t-test). (d) Percentage of ZHBTc4 cells showing reporter 
expression in transient transfections upon Tc addition. Data are means ± s.e.m. n = 3: ***p < 0.001, *p < 0.05 
versus mock; **p < 0.01 between cells expressing the same fragment but maintained in ES medium versus EMFI 
medium +  Tc (Student’s t-test). (e–h) lacZ reporter activity driven by fragment #1 (e,f) and fragment #2 (g,h) in 
transient transgenic embryos at E3.5 (e,g; scale bar 10 μ m) and E7.5 (f,h). (f ’) is a sagittal section of the embryo 
shown in (f); scale bar 110 μ m.
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In vivo activity of regulatory elements from the Cdx2 locus. We next tested the ability of the frag-
ments tested in TS cells to drive reporter activity in vivo. Fragment #1 is reported to drive ubiquitous activity 
at early preimplantation stages14, in line with our observations in ES cells and TS cells. Our results support this 
view, showing fragment #1-driven lacZ reporter expression throughout the preimplantation embryo (Fig. 3e, 
Supplementary Table S1). However, transient transgenesis with fragment #1 at E6.5-E7.5 only resulted in 
β -galactosidase expression in the posterior ectoderm and extraembryonic mesoderm of just one embryo (Fig. 3f), 
indicating that fragment #1 does not reproduce the Cdx2 expression pattern in TE derivatives. Fragment #2 did 
not direct reporter expression in the blastocyst above background levels (Fig. 3g, Supplementary Table S1) and 
did not drive ExE-specific expression in the postimplantation embryo (Fig. 3h), consistent with its lack of activity 
in TS cells. However, we detected consistent β -galactosidase expression in the extraembryonic endoderm in two 
out of six transgenic embryos, reminiscent of the expression pattern of FoxA27,18. These data show that none of 
these genomic fragments drives expression in TE-derivatives and that the TEE is the only blastocyst TE-specific 
Cdx2 element identified so far.
To identify other regulatory elements that might drive Cdx2 expression in TE derivatives, we examined avail-
able data on the distribution of histone modifications associated with enhancer activity (H3K4me1, H3K27ac)19 
in placenta and small intestine, sites of Cdx2 gene expression during development20, and in ES cells, where Cdx2 
is inactive. This analysis identified a region downstream of Cdx2 that was enriched for H3K4me1 and H3K27ac 
in placenta and small intestine but not in ES cells (fragment #3; Fig. 4a). This fragment was active in the TE in 
transient transgenic blastocysts (Fig. 4b; Supplementary Table S1), as detected by co-localization with endoge-
nous CDX2 in 75% of the mRFP positive cells. We then tested its activity in TS cells, finding that it drove reporter 
Figure 4. A novel regulatory element drives Cdx2 expression in the TE, TS and a subset of extraembryonic 
cells. (a) UCSC genome browser view of the Cdx2 region (mm9; chr5:148,081,494-148,134,458) showing (from 
top to bottom) ENCODE tracks of histone modifications for active enhancers (H3K4me1 and H3K27ac) in the 
placenta, small intestine and ES cells. The TEE and fragments #1 and #2 are highlighted in grey. Fragment #3 is 
highlighted in red. (b) mRFP (red) activity driven by fragment #3 in blastocysts, showing co-localization with 
CDX2 (green). Nuclei (blue) were stained with DAPI. (c) Fragment #3 is active in TS cells. Expression driven by 
fragments #1 and #3 were compared to Oct4DE. Data are means ± s.e.m. n = 6. **p < 0.01 (Student’s t-test).  
(d) LacZ reporter activity driven by fragment #3 in transient transgenic embryos. (d’) Sagittal section of the 
embryo shown in (c). ExE, extraembryonic ectoderm; EcC, ectoplacental canal. Scale bar, 10 μ m (b), 110 μ m (d,d’).
www.nature.com/scientificreports/
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expression to similar levels as fragment #1 (Fig. 4c). However, when we tested if this genomic fragment was 
active in the ExE at postimplantation stages, we found directed reporter expression at E6.5 only in a subset of 
cells located in the extraembryonic portion (Fig. 4d,d’) that could correspond to the ectoplacental canal, a site of 
endogenous Cdx2 expression20, but not throughout the ExE.
Discussion
The first intercellular distinction in the developing embryo is produced with the formation of the trophectoderm. 
The actions of the core set of transcription factors responsible for establishing and maintaining the first lineages 
are well understood5,21,22, but little is known about how the expression of these factors themselves is regulated and 
limited to specific subpopulations of cells in the embryo. In addition, the same transcription factors operate in 
various contexts during embryogenesis. Thus, the identification of non-coding regulatory sequences responsible 
for the expression of the main transcription factors permits a better understanding of the dynamic expression 
profile of these genes.
In this study, we sought to identify regulatory elements implicated in different phases of Cdx2 expression in 
the early stages of mouse development. The Cdx2-TEE enhancer is a Hippo and Notch response element that 
reproduces the early onset of Cdx2 expression, when the TE is first specified10. To our surprise, we find that the 
TEE does not drive reporter activity past the blastocyst stage in TE derivatives such as the ExE, and is also inactive 
in TS cells. We have shown that the transcriptional effectors of the Hippo and Notch signaling pathways (TEAD4 
and RBPJ, respectively) converge on the TEE to regulate Cdx2 expression in the blastocyst10. A possible explana-
tion is that although Tead4 is expressed in the ExE of the postimplantation embryo23, the input from Notch is only 
transiently evident in a few cells of this tissue24. In the search for extraembryonic regulatory elements of Cdx2, we 
identified a regulatory element in the first intron of Cdx2 that directs reporter expression in TS cells but does not 
direct extraembryonic expression in the embryo. This element is active not only in TS cells but also in ES cells, 
discarding it as an extraembryonic-specific enhancer. In addition, we characterize a novel regulatory element 
downstream of Cdx2 that directs reporter expression in the blastocyst, in TS cells and in a subpopulation of the 
extraembryonic component of the gastrulating embryo.
Our results show that the regulation of Cdx2 in TE and TS cells depends on different inputs and that Cdx2 reg-
ulation is context-dependent. Strikingly, although TS cells are derived from the TE, discrete Cdx2 cis-regulatory 
elements active in the TE show different ability to direct reporter expression in TS cells, and do not reproduce the 
postimplantation extraembryonic expression pattern of Cdx2.
Similar findings have been shown for the regulation of Oct4. In ES cells, two enhancers have been described; 
however, only one is able to direct reporter expression to the ICM of the blastocyst15,25. TS cells display a gene 
expression profile that resembles trophoblast cells in the ExE rather than the TE6,12, and some key factors of the 
trophoblast gene regulatory network are expressed only in the postimplantation ExE26. Although this suggests 
that TS cells share their regulation with the ExE and are distinct from the TE, we have not been able to identify 
any Cdx2 enhancer that drives robust TS and ExE expression. The RNA profiles of TS cells derived at E3.5 or E6.5 
cluster according to the developmental stage27, suggesting that additional regulatory differences may exist.
It is thus tempting to propose a two-stage regulatory model for Cdx2. In this model, initiation of Cdx2 would 
depend strongly on the TEE, by reading Hippo and Notch inputs; in contrast, Cdx2 extraembryonic expression 
upon implantation would be maintained by a combination of other elements that are active in TS cells and the 
postimplantation embryo. The different requirements for Cdx2 in the blastocyst TE and in TS cells have been 
recently illustrated by the reprogramming of mouse embryonic fibroblasts to TS cells, a process that does not 
require Cdx228,29. What we describe here for Cdx2 regulation may occur in a similar fashion in other genes in 
the TS gene regulatory network, and it will be interesting to systematically characterize the regulatory elements 
unique to TS cells versus those shared with the TE or ExE lineages.
Methods
Construct generation for microinjection. Cdx2 genomic regions were amplified by PCR using BAC 
RP245I065 as template. This BAC covers the whole intergenic region containing mouse Cdx2 and was obtained 
from the BACPAC Resources Center (http://bacpac.chori.org/). Primers used for PCR, together with the 
lengths of corresponding amplified fragments, were as follows: TEE, CACACGGATGAATTGTCTGG and 
AACAGGGACAGGTGAGATGG (1329 bp); fragment #1, AGTTGGAGAGGTCTCACATCAAA and AGATT 
TGGTTCTGTCGTCTTCTG (563 bp), #2-LacZ, TCCATTATTCGCTCTAAAACAGC and CGAGTCACT 
GATCTGTGTAACGA (1842 bp), #2-mRFP, GTGTCTCTGGGTCTGAAGCT and CTGTAGGAAAGG 
AAGGGTGT (509 bp), #3, GTTTTGTTTTCCCGGTTGTG and TGTCTGAGATCCTGTCTTAG (4484 bp). 
Each fragment was subcloned and linearized as described10 for transgenic assays. Genomic fragments used in TS 
and ZHBTc4 cell transfections were subcloned in the beta-globin promoter/mRFP reporter construct.
Embryo collection and culture. For characterization of TEE-lacZ and TEE-mRFP mouse lines, E0.5 
embryos were collected from swollen ampulas, treated with hyaluronidase (Sigma) to remove cumulus cells and 
cultured until the blastocyst stage at 37.5 °C in 5% CO2 in air, in M16 medium (Sigma) covered with mineral oil 
(Sigma).
Transient transgenic analysis. For the generation of transient transgenic embryos, F1 (C57Bl/6xCBA) 
females were superovulated to obtain fertilized oocytes30. Each construct was microinjected at 3–6 ng/μ l into 
the pronucleus of fertilized oocytes at 0.5 dpc. Blastocysts were stained for mRFP and CDX2 and blasto-
meres scored for co-staining. Postimplantation embryos were collected from E6.5 to E7.5, fixed, and stained 
for β -galactosidase activity. Transgenic efficiency was calculated by genotyping embryos for LacZ (LacZ F, 
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GCGACTTCCAGTTCAACATC, LacZ R, GATGAGTTTGGACAAACCAC) and Myogenin as an internal con-
trol (F, CCAAGTTGGTGTCAAAAGCC and R, CTCTCTGCTTTAAGGAGTCAG).
Animal experimentation. Animal procedures were performed in accordance with Spanish (RD 53/2013) 
and European (Directive 2010/63/EU) regulations, approved by the UAM (Universidad Autónoma de Madrid) 
Animal Experimentation Ethics Committee, and authorized by the Regional Government of Madrid (reference 
CNIC15/14).
Outgrowth formation. For trophoblast outgrowth formation assays, blastocysts were individually cul-
tured in EMFI-TS medium in μ -Slide 8 well chambered coverslips (ibidi) pre-coated with 0.1% gelatin (Sigma)31. 
Outgrowths were cultured for 48–72 h and subsequently stained for CDX2 or β -galactosidase activity. Individual 
outgrowths were genotyped directly as previously described for preimplantation embryos10, after observation and 
X-Gal staining.
Trophoblast stem cell derivation and cell culture. TS cells were derived essentially as described3,32. 
E3.5 blastocysts were obtained from wild-type superovulated females. For the derivation of TSL cells, wild-type 
females were mated with TEE-lacZ heterozygote males. TSR cells were derived from crosses of homozygote 
TEE-mRFP and wild-type mice. Blastocysts were plated onto 4 well plates coated with 5 × 104 inactive mouse 
embryonic fibroblasts (EMFIs) in EMFI-TS medium supplemented with 37.5 ng/ml FGF4 and 1.5 μ g/ml heparin. 
Plated blastocysts hatch, adhere to the well and form outgrowths on the dish. Depending on the individual blas-
tocyst, outgrowths were harvested by trypsinization on days 4 to 6, and subsequently replated until TS cell colo-
nies were clearly visible. After 20–21 days, MEFs were removed and TS-derived cells were cultured in EMFI-TS 
medium on plastic dishes. Twelve independent clones (TSL) were derived from the TEE-lacZ line and 7 TS clones 
(TSR) from the TEE-mRFP mouse line. Four TSL and two TSR clones were selected for further characterization. 
TS lines were genotyped as described10.
The wild type B1-TS cell line and the TSR and TSL cell lines were maintained as described3,17,33. ZHBTc4 
ES cells were cultured on gelatin-coated dishes in ES medium supplemented with 1000 U/μ l LIF (ESGRO-LIF; 
Millipore). Repression of Oct4 (official name Pou5f1) in ZHBtc4 ES cells was induced by addition of tetracycline 
(Sigma) at 1 μ g/ml in ES medium or EMFI-TS medium9 in the presence of 25 ng/ml FGF4 (R&D Systems) and 
1 μ g/ml heparin (Sigma).
Immunohistochemistry. Immunohistochemistry on transient transgenic blastocysts was performed as pre-
viously described34. Cells were cultured on gelatin-coated glass coverslips and fixed in 4% paraformaldehyde in 
PBS. Samples were permeabilized and blocked at room temperature before incubation. The following antibodies 
and dilutions were used: monoclonal mouse anti-CDX2 (MU392-UC, BioGenex) 1:200, rabbit polyclonal living 
colours DsRed (632496 Clontech) 1:500, monoclonal mouse anti-OCT4 (sc-5279, Santa Cruz) 1:200. Nuclei were 
visualized by incubating embryos in 1 μ g/ml DAPI, and F-actin in the cell membrane was detected by staining 
with a 1:300 dilution of rhodamine-phalloidin (Molecular Probes). For double staining of CDX2 and mRFP in 
transient transgenic blastocysts, we scored 43 mRFP positive embryos. In total, we counted 446 mRFP positive 
blastomeres, of which 333 were also CDX2 positive.
Quantitative-PCR. RNA was isolated from TS and ZHBTc4 cells with the RNeasy Mini Kit (Qiagen) 
and then reverse transcribed using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). 
RNA from single blastocysts or from the extraembryonic tissue of E7.5 embryos was isolated with the Arcturus 
PicoPure RNA Isolation Kit (Applied Biosystems) and reverse transcribed using the Quantitect Kit (Qiagen). 
TEE-mRFP blastocysts were selected for RFP expression prior to RNA isolation, and lacZ blastocysts were retro-
spectively assigned as lacZ positive. For E7.5 embryos, the epiblast portion was used for genotyping. cDNA was 
used for quantitative-PCR (qPCR) with Power SYBR® Green (Applied Biosystems) in a 7900HT Fast Real-Time 
PCR System (Applied Biosystems). After qPCR analysis, embryos with low amplification levels for all genes were 
discarded from the analysis. Expression of each gene was normalized to the expression of the housekeeping genes 
Actin and Ywhaz35. Supplementary Table S2 lists the primers used.
Cell transfections. B1-TS cells were transfected in non-adherent dishes with 2.5 μ g DNA (eGFP, empty vec-
tor, Oct4DE, TEE, or fragments #1, #2 and #3) using the Lipofectamine 2000 reagent (Invitrogen). Cell transfec-
tions were performed as previously described32 or using TS medium with 15% of KnockOut Serum Replacement 
(ThermoFisher) instead of serum in order to improve efficiency. ZHBTc4 cells were transfected in 6 well plates 
with 0.8 μ g DNA (eGFP, empty vector, TEE, or fragments #1 and #2) using Lipofectamine 2000. At 6 h after 
transfection, medium was changed and tetracycline added when indicated. Forty-eight hours after transfection, 
transfected cells were counted by flow cytometry (LSRFortessa Flow Cytometer), or random fields per well were 
photographed (Zeiss) and fluorescent cells counted (ImageJ). Regulatory activity is expressed as the proportion 
of red (RFP+ ) cells over to total cells, normalized to transfection efficiency as measured by the number of the 
GFP+ transfected cells.
Chromatin immunoprecipitation. Histone ChIP followed by quantitative PCR (qPCR) was carried out 
as previously described17. Briefly, 50 μ g of precleared cross-linked chromatin from TS cells was incubated over-
night with 5 μ g of antibody followed by 4 h with Sepharose A beads. Eluates were digested with Proteinase K 
(0.5 mg/ml) and Rnase A (0.1 mg/ml), and DNA was phenol-choloroform extracted and recovered by standard 
precipitation with ethanol. The following antibodies were used: anti-H3K4me1 (ab8895; Abcam), anti-H3K4me3 
(ab8580; Abcam), anti IgG (m7023, Sigma). Supplementary Table S2 lists the primers used for ChIP. ChIP data 
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are represented as the fraction of the differences in ct values for each specific primer set between histone mark 
and IgG divided by the IgG ct value.
Cell cycle profiling. A cell-cycle profiling assay was performed to evaluate the capacity of the selected clones 
to differentiate in normal TS culture conditions and upon FGF4 removal. Cell cycle was profiled by flow cytome-
try using an LSRFortessa Flow Cytometer. Briefly, trypsinized cells were fixed in 70% ethanol, treated with RNAse 
at a final concentration of 100 μ g/ml, and resuspended in 0.003% propidium iodide solution. DNA content was 
scored in TS cells (2n/G1 phase), replicating TS cells (up to 4n/S-G2-M), and endoreduplicating cells (4n or 
> 4n). Due to their size, some giant cells might not have been included in the flow cytometry, which was thus 
unable to detect all the differentiated cells.
TS cell infection. Lentiviruses encoding the GFP reporter were generated by transient transfection of 293T 
cells. For transduction, 106 TS cells were seeded in suspension, followed by addition of 0.25 mL vector suspension 
in RPMI medium (1 × 108IU/mL, MOI = 100). Eight hours post infection, vector suspension was removed and 
transduced cells were seeded in a 24 well dish with fresh EMFI-TS medium, and incubated at 37 °C with 5% CO2. 
Transduction efficiencies were evaluated at 48 h post-infection.
TS cell injection. Eight to 10 TSR cells were microinjected into 8-cell stage embryos using standard tech-
niques30. Morulae were incubated overnight in microdrops of M16 medium (Sigma) under mineral oil. 
Endogenous fluorescence was assessed the next day. Immunohistochemistry for CDX2 and mRFP1 was per-
formed as described10.
Imaging. Images of transfected cells were acquired with a Zeiss Axiover 200 M inverted microscope. Nikon 
Eclipse 90i and Olympus BX51 microscopes were used to image histological sections. Confocal images of 
cells were acquired with a Leica SpE microscope (20x or 40x objective). Confocal images of microinjected or 
antibody-stained embryos were acquired with a Leica SP5 confocal microscope. Images were acquired with a 
63× objective and 2× zoom every 2.5 μ m. Images of lacZ-stained blastocysts and outgrowths were obtained with 
a Leica DMIRE2 inverted microscope. Images were prepared for figures using Adobe Photoshop CS5.
Statistics. Statistical analyses were performed with GraphPad Prism 5. Data are presented as means ± s.e.m 
or ± s.d. as indicated in the figure legends. Differences were considered statistically significant at p < 0.05. p values 
were calculated by Student’s t-test for comparisons of two groups, and by ANOVA with Bonferroni post-test for 
multiple pair-wise comparisons.
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